Center on Aging, MC-5215, University of Connecticut Health Center Farmington, CT 06030-5215, USA.
J Nutr Health Aging. 2013 Jan;17(1):76-80. doi: 10.1007/s12603-012-0415-3.
Identify relationships and evaluate effects of long chain polyunsaturated fatty acids (LCPUFA) on frailty and physical performance.
Randomized, double blind pilot study.
University General Clinical Research Center.
126 postmenopausal women.
2 fish oil (1.2g eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) or 2 placebo (olive oil) capsules per day for 6 months. All participants received calcium and vitamin D supplements.
Fatty acid levels, frailty assessment, hand grip strength, 8 foot walk, body composition, medical history and co-morbidities, nutrient intake, and inflammatory biomarkers taken at baseline and 6 months.
At baseline, those with greater red blood cell (RBC) DHA and DHA/arachidonic acid (AA) presented with less frailty (r = -0.242, p=0.007 and r = -0.254, p=0.004, respectively). Fish oil supplementation resulted in higher RBC DHA and lower AA compared to baseline and placebo (p<0.001) and an improvement in walking speed compared to placebo (3.0±16 vs. -3.5±14, p=0.038). A linear regression model included age, antioxidant intake (selenium and vitamin C), osteoarthritis, frailty phenotype, and tumor necrosis factor alpha (TNFα). The model explained 13.6% of the variance in the change in walking speed. Change in DHA/AA (p=0.01) and TNFα (p=0.039), and selenium intake (p=0.031) had the greatest contribution to change in walking speed.
Physical performance, measured by change in walking speed, was significantly affected by fish oil supplementation. Dietary intake of antioxidants (selenium and vitamin C) and changes in TNFα also contributed to change in walking speed suggesting LCPUFA may interact with antioxidants and inflammatory response to impact physical performance.
确定长链多不饱和脂肪酸 (LCPUFA) 与虚弱和身体表现的关系,并评估其影响。
随机、双盲试验研究。
大学综合临床研究中心。
126 名绝经后妇女。
每天服用 2 粒鱼油(1.2g 二十碳五烯酸 [EPA] 和二十二碳六烯酸 [DHA])或 2 粒安慰剂(橄榄油)胶囊,持续 6 个月。所有参与者均接受钙和维生素 D 补充剂。
脂肪酸水平、虚弱评估、手握力、8 英尺步行、身体成分、病史和合并症、营养摄入以及炎症生物标志物,均在基线和 6 个月时进行测量。
在基线时,红细胞 (RBC) DHA 和 DHA/花生四烯酸 (AA) 水平较高的人表现出较少的虚弱(r = -0.242,p=0.007 和 r = -0.254,p=0.004)。与基线和安慰剂相比,鱼油补充剂可使 RBC DHA 升高,AA 降低(p<0.001),并且与安慰剂相比,步行速度提高(3.0±16 对 -3.5±14,p=0.038)。线性回归模型纳入了年龄、抗氧化剂摄入(硒和维生素 C)、骨关节炎、虚弱表型和肿瘤坏死因子-α (TNFα)。该模型解释了步行速度变化的 13.6%。DHA/AA 的变化(p=0.01)和 TNFα(p=0.039)以及硒的摄入(p=0.031)对步行速度的变化贡献最大。
通过步行速度的变化衡量,身体表现受到鱼油补充的显著影响。抗氧化剂(硒和维生素 C)的饮食摄入以及 TNFα 的变化也有助于步行速度的变化,这表明 LCPUFA 可能与抗氧化剂和炎症反应相互作用,从而影响身体表现。